Literature DB >> 21599537

Hemoglobin conjugates with antioxidant enzymes (hemoglobin-superoxide dismutase-catalase) via poly(ethylene glycol) crosslinker for protection of pancreatic beta RINm5F cells in hypoxia.

Venkatareddy Nadithe1, You Han Bae.   

Abstract

A low p50 hemoglobin (Hb) (p50 indicates O(2) tension at which Hb is half-saturated)-based oxygen carrier conjugated to antioxidant enzymes via dicarboxymethylated poly(ethylene glycol) (PEG) linker may have the beneficial effect in protecting pancreatic beta cells from severe hypoxia at transplantation sites. In this study, the oxygen dissociation curves, Hill plots, Bohr Effect, and oxygen content of Hb conjugates were measured. The protective effect due to incubation of Hb-conjugates (Hb/PEG molar ratio 1:10) with pancreatic beta cells (RINm5F) against hypoxia (6%, 3%, and 1% oxygen) was evaluated by an MTT assay and confocal microscopy. Quantitatively, Hb conjugates with antioxidant enzymes offered statistically significant protection (p<0.01, increased viability ∼80%) from hypoxia compared to control cells in 1% oxygen environment. Confocal images also showed that the low p50 Hb conjugates with antioxidants protected RINm5F cells from hypoxia. © Mary Ann Liebert, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21599537      PMCID: PMC3179617          DOI: 10.1089/ten.TEA.2010.0509

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  49 in total

1.  Numerical simulation of oxygen delivery to muscle tissue in the presence of hemoglobin-based oxygen carriers.

Authors:  Jaqunda N Patton; Andre F Palmer
Journal:  Biotechnol Prog       Date:  2006 Jul-Aug

2.  Isolation and characterization of a new hemoglobin derivative cross-linked between the alpha chains (lysine 99 alpha 1----lysine 99 alpha 2).

Authors:  R Chatterjee; E V Welty; R Y Walder; S L Pruitt; P H Rogers; A Arnone; J A Walder
Journal:  J Biol Chem       Date:  1986-07-25       Impact factor: 5.157

3.  Performance characteristics of Hemox-Analyzer for assessment of the hemoglobin dissociation curve.

Authors:  R Guarnone; E Centenara; G Barosi
Journal:  Haematologica       Date:  1995 Sep-Oct       Impact factor: 9.941

Review 4.  Perfluorocarbon-based oxygen delivery.

Authors:  Jean G Riess
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2006

5.  Mixed S-nitrosylated polymerized bovine hemoglobin species moderate hemodynamic effects in acutely hypoxic rats.

Authors:  David Irwin; Paul W Buehler; Abdu I Alayash; Yiping Jia; Joe Bonventura; Ben Foreman; Molly White; Robert Jacobs; Brian Piteo; Martha C TissotvanPatot; Karyn L Hamilton; Robert W Gotshall
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-24       Impact factor: 6.914

6.  Biocompatible and biodegradable polymersome encapsulated hemoglobin: a potential oxygen carrier.

Authors:  Shahid Rameez; Houssam Alosta; Andre F Palmer
Journal:  Bioconjug Chem       Date:  2008-04-29       Impact factor: 4.774

7.  Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate.

Authors:  Andreia Biolo; Ruth Greferath; Deborah A Siwik; Fuzhong Qin; Eugene Valsky; Konstantina C Fylaktakidou; Srinivasu Pothukanuri; Carolina D Duarte; Richard P Schwarz; Jean-Marie Lehn; Claude Nicolau; Wilson S Colucci
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

Review 8.  Review: behaviour of endothelial cells faced with hypoxia.

Authors:  E Paternotte; C Gaucher; P Labrude; J-F Stoltz; P Menu
Journal:  Biomed Mater Eng       Date:  2008       Impact factor: 1.300

9.  Reactive oxygen species-mediated pancreatic beta-cell death is regulated by interactions between stress-activated protein kinases, p38 and c-Jun N-terminal kinase, and mitogen-activated protein kinase phosphatases.

Authors:  Ni Hou; Seiji Torii; Naoya Saito; Masahiro Hosaka; Toshiyuki Takeuchi
Journal:  Endocrinology       Date:  2008-01-10       Impact factor: 4.736

10.  Targeted O2 delivery by low-P50 hemoglobin: a new basis for O2 therapeutics.

Authors:  Amy G Tsai; Kim D Vandegriff; Marcos Intaglietta; Robert M Winslow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-06-12       Impact factor: 4.733

View more
  2 in total

1.  Poly(ethylene glycol) cross-linked hemoglobin with antioxidant enzymes protects pancreatic islets from hypoxic and free radical stress and extends islet functionality.

Authors:  Venkatareddy Nadithe; Deepa Mishra; You Han Bae
Journal:  Biotechnol Bioeng       Date:  2012-04-08       Impact factor: 4.530

2.  A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume.

Authors:  Yuzhu Bian; Thomas Ming Swi Chang
Journal:  Artif Cells Nanomed Biotechnol       Date:  2014-10-09       Impact factor: 5.678

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.